Patient expectations of benefit from systemic treatments for metastatic prostate cancer

BACKGROUND: Metastatic prostate cancer is incurable, but systemic therapies can improve quality of life and prolong survival. Accurate perceptions of treatment risks and benefits are vital as patients with metastatic disease make treatment decisions. We assessed treatment‐related expectations for be...

Descripción completa

Detalles Bibliográficos
Autores principales: Oswald, Laura B., Kasimer, Rachel, Rappazzo, Katherine, Fought, Angela J., Penson, David F., Morgans, Alicia K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997053/
https://www.ncbi.nlm.nih.gov/pubmed/31840434
http://dx.doi.org/10.1002/cam4.2783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997053/
https://www.ncbi.nlm.nih.gov/pubmed/31840434
http://dx.doi.org/10.1002/cam4.2783

Ejemplares similares